Mattia Utichi

Mattia Utichi

Auto-generated profile, based on publicly available information

Mattia Utichi

Cancer Structural Biology, Danish Cancer Institute, 2100, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MAMatteo Arnaudi
Matteo Arnaudi
MUMattia Utichi
Mattia Utichi
KDKristine Degn
Kristine Degn
MTMatteo Tiberti
Matteo Tiberti
LBLudovica Beltrame
Ludovica Beltrame
EPElena Papaleo
Elena Papaleo
The role of genomic variants in disease has expanded significantly with the advent of advanced sequencing techniques. The rapid increase in identified genomic variants has led to many variants being classified as Variants of Uncertain Significance or as having conflicting evidence, posing challenges for their interpretation and characterization. Additionally, current methods for predicting pathogenic variants often lack insights into the underlying molecular mechanisms. Here, we introduce MAVISp ( M ulti-layered A ssessment of V arIants by S tructure for p roteins), a modular structural framework for variant effects, accompanied by a web server ( https://services.healthtech.dtu.dk/services/MAVISp-1.0/ ) to enhance data accessibility, consultation, and reusability. MAVISp currently provides data over 1000 proteins, encompassing more than eight million variants. A team of biocurators regularly analyzes and updates protein entries using standardized workflows, incorporating free energy calculations or biomolecular simulations. We illustrate the utility of MAVISp through selected case studies. The framework facilitates the analysis of variant effects at the protein level and has the potential to advance the understanding and application of mutational data in disease research.

7 April 2026 in Protein Science
Verified
Journal Article
Open access
MAMatteo Arnaudi
Matteo Arnaudi
MUMattia Utichi
Mattia Utichi
KDKristine Degn
Kristine Degn
MTMatteo Tiberti
Matteo Tiberti
LBLudovica Beltrame
Ludovica Beltrame
EPElena Papaleo
Elena Papaleo
The role of genomic variants in disease has expanded significantly with the advent of advanced sequencing techniques. The rapid increase in identified genomic variants has led to many variants being classified as Variants of Uncertain Significance or as having conflicting evidence, posing challenges for their interpretation and characterization. Additionally, current methods for predicting pathogenic variants often lack insights into the underlying molecular mechanisms. Here, we introduce MAVISp ( M ulti‐layered A ssessment of V ar I ants by S tructure for p roteins), a modular structural framework for variant effects, accompanied by a web server ( https://services.healthtech.dtu.dk/services/MAVISp-1.0/ ) to enhance data accessibility, consultation, and re‐usability. MAVISp currently provides data on over 1000 proteins, encompassing more than 10 million variants. A team of biocurators regularly analyzes and updates protein entries using standardized workflows, incorporating free‐energy calculations and biomolecular simulations. We illustrate the utility of MAVISp through selected case studies. The framework facilitates the analysis of variant effects at the protein level and has the potential to advance the understanding and application of mutational data in disease research.

27 February 2025 in Current Opinion in Structural Biology
Verified
Journal Article
Open access
MAMatteo Arnaudi
Matteo Arnaudi
MUMattia Utichi
Mattia Utichi
MTMatteo Tiberti
Matteo Tiberti
EPElena Papaleo
Elena Papaleo
Missense variants can affect the severity of disease, choice of treatment, and treatment outcomes. While the number of known variants has been increasing at a rapid pace, available evidence of their clinical effect has been lagging behind, constituting a challenge for clinicians and researchers. Multiplexed assays of variant effects (MAVEs) are important to close the gap; nonetheless, computational predictions of pathogenicity are still often the only available data for scoring variants. Such methods are not designed to provide a mechanistic explanation for the effect of amino acid substitutions. To this purpose, we propose structure-based frameworks as ensemble methodologies, with each method tailored to predict a different aspect among those exerted by amino acid substitutions to link predicted pathogenicity to mechanistic indicators. We review available frameworks, as well as advancements in underlying structure-based methods that predict variant effects on several protein features, such as protein stability, biomolecular interactions, allostery, post-translational modifications, and more.

30 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
OAOana Nicoleta Antonescu
Oana Nicoleta Antonescu
MUMattia Utichi
Mattia Utichi
VSValentina Sora
Valentina Sora
MTMatteo Tiberti
Matteo Tiberti
EMEmiliano Maiani
Emiliano Maiani
EPElena Papaleo
Elena Papaleo
Short Linear Motifs (SLiMs) play a pivotal role in mediating interactions between intrinsically disordered proteins and their binding partners. SLiMs exhibit sequence degeneracy and undergo regulation through post-translational modifications, including phosphorylation. The flanking regions surrounding the core motifs also exert a crucial role in shaping the modes of interaction. In this study, we aimed to integrate biomolecular simulations, in silico high-throughput mutational scans, and biophysical experiments to elucidate the structural details of phospho-regulation in a class of SLiMs crucial for autophagy, known as LC3 interacting regions (LIRs). As a case study, we investigated the interaction between optineurin and LC3B. Optineurin LIR perfectly exemplify a class of LIR where there is a complex interplay of different phosphorylations and a N-terminal helical flanking region to be disentangled. Our work unveils the unexplored role of the N-terminal flanking region upstream of the LIR core motif in contributing to the interaction interface. The results offer an atom-level perspective on the structural mechanisms and conformational alterations induced by phosphorylation in optineurin and LC3B recognition, along with of effects of mutations on the background of the phosphorylated form of the protein. Additionally, we assessed the impact of disease-related mutations on optineurin, accounting for different functional features. Notably, we established an approach based on Microfluidic Diffusional Sizing as a novel method to investigate the binding affinity of SLiMs to target proteins, enabling precise measurements of the dissociation constant for a selection of variants identified in the in silico mutational screening. Overall, our work provides a versatile toolkit to characterize other LIR-containing proteins and their modulation by phosphorylation or other phospho-regulated SLiMs, thereby advancing the understanding of important cellular processes.

2 April 2025 in bioRxiv
Verified
Preprint
Open access
KDKristine Degn
Kristine Degn
MUMattia Utichi
Mattia Utichi
PBPablo Sánchez-Izquierdo Besora
Pablo Sánchez-Izquierdo Besora
MTMatteo Tiberti
Matteo Tiberti
EPElena Papaleo
Elena Papaleo
Change in protein stability, quantified as the change in Gibbs free energy of folding (ΔΔG) in kcal/mol, plays a crucial role in functional alterations of proteins, with misfolding and destabilization commonly associated with pathogenicity. The past two decades have brought the development of bioinformatics tools leveraging evolutionary knowledge, empirical force fields, and machine learning to predict stability alterations. However, existing tools are often optimized towards or trained on limited experimental data, leading to unbalanced datasets and potential overfitting. The research objective is to benchmark selected stability predictors using an unbiased and balanced dataset, with AlphaFold structures as input. We demonstrate a performance decline when balancing data across amino acids, stabilizing and destabilizing mutations, and protein representatives, highlighting that redundancy alone is insufficient for benchmarking correction. Additionally, we illustrate that a protein structure ensemble from molecular dynamics acts as a superior input compared to a single static structure. At the same time, coarse-grained methodologies tend to decrease the output quality.

5 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MUMattia Utichi
Mattia Utichi
HMHenri-Baptiste Marjault
Henri-Baptiste Marjault
MTMatteo Tiberti
Matteo Tiberti
EPElena Papaleo
Elena Papaleo
Macroautophagy (hereafter autophagy) is a cellular recycling pathway that requires different ATG (autophagy-related) proteins to generate double-membraned autophagosomes. ATG9A, a multi-spanning membrane protein, plays a crucial role in this process as the only transmembrane component of the core autophagy machinery. ATG9A functions as a lipid scramblase, redistributing lipids between membrane leaflets for the expanding autophagosome membrane. Structural studies have revealed that ATG9A forms a homotrimer with an interlocked domain-swapped architecture and a network of internal hydrophilic cavities. This configuration underlies its role in lipid transfer and membrane remodeling together with the lipid transporter ATG2A. ATG9A dysfunction has also been linked to human disease, as specific ATG9A mutations cause neurodevelopmental or neurodegenerative phenotypes. Additionally, ATG9A is altered in cancer, promoting pro-tumorigenic traits. However, most missense variants in ATG9A remain uncharacterized, posing a significant challenge for interpreting genomic data. In this study, we employed in silico saturation mutagenesis approach using the MAVISp (Multi-layered Assessment of VarIants by Structure) framework to predict the impact of every missense mutation in ATG9A. By analyzing multiple structural assemblies of ATG9A (monomer, trimer, and the ATG9A-ATG2A complex), we evaluated diverse mechanistic indicators of variant impact, including protein stability, long-range conformational changes, effects on multimerization interfaces, and alterations in post-translational modifications. We integrated the structure-based predictions with Variant Effect Predictors from recent deep-learning or evolutionary-based models and cross-referenced known variants catalogued in ClinVar, COSMIC, and cBioPortal. Finally, we predicted mechanistic indicators for all possible variants with structural coverage not yet reported in the disease-related databases supported by MAVISp. Our analyses identified a group of potentially damaging variants in ATG9A and the possible molecular mechanisms underlying their effects. Together, this work provides a roadmap for interpreting missense variants in autophagy regulators and highlights specific ATG9A mutations that deserve further investigation in the context of human disease.